Hara Capital’s GSK GSK Stock Holding History

Hara Capital’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$7.46K	Hold	134	–	–	﹤0.01%	270
2025 Q4	$6.63K	Hold	134	–	–	﹤0.01%	261
2025 Q3	$5.78K	Hold	134	–	–	﹤0.01%	258
2025 Q2	$5.15K	Hold	134	–	–	﹤0.01%	289
2025 Q1	$5.19K	Sell	134 -134	-50%	-$4.91K	﹤0.01%	257
2024 Q4	$9.06K	Buy	268 +134	+100%	+$4.82K	﹤0.01%	276
2024 Q3	$5.48K	Buy	+134	New	+$5.48K	﹤0.01%	264

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hara Capital's GSK Position: Q1 2026 in Review

Hara Capital held its GSK (GSK) position steady in Q1 2026 at 134 shares worth $7.46K. The position accounts for ﹤0.01% of the portfolio, ranked #270.

Hara Capital first reported a position in GSK in Q3 2024 and has held it in 7 quarters since. The position peaked at $9.06K in Q4 2024. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Hara Capital held 134 shares of GSK worth $7.46K as of Q1 2026.
Hara Capital left its GSK share count unchanged in Q1 2026.
GSK made up ﹤0.01% of Hara Capital's portfolio in Q1 2026, its #270 holding.
Hara Capital first reported a position in GSK in Q3 2024 and has held it in 7 quarters since.
Hara Capital's GSK position peaked at $9.06K in Q4 2024.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Hara Capital's 13F filing for Q1 2026, filed 14 May 2026.